Human Anti-IL12 x Anti-IL18 Bispecific Antibody (IgG-IgG) (BSIG-H335)

Anti-IL12 x Anti-IL18 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-IL12 and anti-IL18 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Arthritis therapy.

Datasheet INQUIRY

Specifications

Targets

IL12 & IL18

Type

IgG-IgG

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Arthritis

Targets

Target 1

IL12

Gene ID

3592

UniProt ID

P29459

Alternative Names

P35; CLMF; NFSK; NKSF1; IL-12A; IL12; IL-12; interleukin 12A

Target 2

IL18

Gene ID

3606

UniProt ID

A0A024R3E0

Alternative Names

IGIF; IL-18; IL-1g; IL1F4; interleukin 18; IL18

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Human Anti-IL12 x Anti-IL18 Bispecific Antibody (IgG-IgG) (BSIG-H335). Click the button below to contact us or submit your feedback about this product.

Human Anti-IL12 x Anti-IL18 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-H335)

Specifications

Targets

Customer Reviews and Q&As